Help! Please Register
forex kings
  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Astellas Pharma Inc.

conference highlightsConference Highlights

Focus on Fungal Infections 14


Antifungal Susceptibility
  1. ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA SPP. ISOLATED FROM PEDIATRIC PATIENTS: A SURVEY OF FOUR CHILDREN'S HOSPITALS
    Foraker E1, Zaoutis TE2, Levin S1, McGowan KL2, Mortensen J3, Campos J4, Klein JD5
    1The Infectious Disease Laboratory, Christiana Care Health Services, Wilmington, USA
    2The Children's Hospital of Philadelphia, Philadelphia, USA
    3Cincinnati Children's Hospital Medical Center, Cincinnati, USA


  2. ACTIVITY OF ANIDULAFUNGIN AGAINST CANDIDA ISOLATES FROM FIVE EUROPEAN COUNTRIES
    Johnson EM, 1 Goldstein BP, 2 Davey KG, 1 Fraser MA 1
    1HPA Mycology Reference Laboratory, Kingsdown, UK
    2Vicuron Pharmaceuticals, King of Prussia, USA


  3. EFFECT OF CONCENTRATION EXCEEDING MICS OF ANTIFUNGAL AGENTS ON THE SELECTION OF RESISTANT MUTANTS OF CANDIDA SPP. AND CRYPTOCOCCUS NEOFORMANS.
    Nguyen K, Arora D, Nguyen MH, Clancy CJ
    University of Florida College of Medicine, Gainesville, USA


  4. In Vitro Activities of Three New Triazoles (Voriconazole, Posaconazole And Ravuconazole) Compared with Fluconazole and Itraconazole against Candida glabrata Species
    Paritpokee S, Isada CM, Bernard H, Warner DK, Procop GW, Hall GS
    The Cleveland Clinic Foundation, Cleveland, USA


  5. ACQUIRED RESISTANCE AND REVERSIBILITY OF ASPERGILLUS FUMIGATUS TO ITRACONAZOLE
    Chen J, Wan Z, Li R.
    Peking University First Hospital, Research Center for Medical Mycology, Peking University, Beijing, China


  6. EXTRA COPIES OF THE ASPERGILLUS FUMIGATUS SQUALENE EPOXIDASE GENE CONFER RESISTANCE TO TERBINAFINE: A GENETIC APPROACH TO STUDY GENE-DOSE DEPENDENT RESISTANCE TO ANTIFUNGALS IN ASPERGILLUS FUMIGATUS
    Kontoyiannis DP1, Liu W1, May GS2
    1Department of Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, USA
    2Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, USA


  7. INVESTIGATION OF ASSOCIATION OF HETERORESISTANCE TO FLUCONAZOLE (FCZ) IN C, NEOFORMANS MENINGITIS (CM), DEVELOPMENT OF RESISTANCE (R) AND FAILURE OF THERAPY (RX)
    Stevens DA, McCullough MJ, Espiritu M, Parmar R
    Sta. Clara Valley Med. Ctr., Stanford Univ., Calif. Inst. For Med. Research; San Jose and Stanford, USA


top of page    




View other categories
Antifungal Agents | Antifungal Combinations | Antifungal Susceptibility | Basic Mycology
Case Reports | Clinical Mycology | Animal Models | Diagnostics | View All





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif